Advances in Relapsed/Refractory Myeloma: Keeping Pace With a Rapidly Evolving Treatment Landscape

This online program is based on a live satellite symposium covering the latest therapeutic strategies for the management of relapsed/refractory multiple myeloma including the latest clinical data on the safety and efficacy of emerging agents. Watch the on-demand webcast download the slidesets from the satellite symposium and read an expert commentary.

Share

Program Content

Activities

RR MM 2022 Downloadable Slides 1
Current Treatment Options at First Relapse in Relapsed/Refractory Myeloma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2022

Expires: June 06, 2023

RR MM 2022 Downloadable Slides 2
Relapsed/Refractory Multiple Myeloma: Subsequent Therapy and Beyond
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2022

Expires: June 06, 2023

RR MM 2022 Downloadable Slides 3
CAR T Cells and Investigational Bispecific Antibodies in MM
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2022

Expires: June 06, 2023

No activities added yet

Activities

Advances in R/R MM
Experts Answer Pressing Questions on Recent Advances in Treatment of Relapsed/Refractory Multiple Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 18, 2022

Expires: August 17, 2023

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

GlaxoSmithKline

Janssen administered by Scientific Affairs

Karyopharm Therapeutics

Regeneron Pharmaceuticals, Inc.